Enzymatic degradation inhibitors: Vigabatrin
By its chemical structure, vigabatrin is a direct structural analogue of gamma-aminobutyric acid. The main target of this drug is the enzyme GABA transaminase, whose physiological role is the breakdown (catabolism) of GABA.
The pharmacological effect develops because the drug irreversibly binds to this enzyme and inhibits its function. The consequence of this action is a pronounced increase in the concentration of the inhibitory neurotransmitter directly in brain tissues. The drug has a broad antiepileptic activity profile.
Main indications for prescription:
- Treatment of partial-onset seizures.
- Prevention of major (tonic-clonic) seizures.
Neuronal uptake blockers: Tiagabine
This substance does not occur naturally and is a product obtained via targeted chemical synthesis. The mechanism of action of tiagabine is fundamentally different from the previous drug. It aims to block a specialized transport system that normally pumps GABA back into the neuron.
By inhibiting neuronal reuptake from the synaptic cleft, the drug allows the neurotransmitter to remain in the active zone longer, increasing its local concentration.
Clinically, this agent is considered primarily as an adjunctive drug for baseline therapy. It is used for the prevention of both partial and generalized epileptic seizures.
Important application features:
- The drug is capable of potentiating (significantly enhancing) the effects of other central nervous system depressants. These include benzodiazepines, barbiturates, and ethanol.
- Adverse reactions that may develop during administration include pronounced sedation, increased drowsiness, various depressive disorders, and psychotic states.
Agents with atypical mechanisms: Gabapentin
Gabapentin (also known by the brand name Neurontin) was originally developed as a lipophilic structural analogue of GABA designed to stimulate GABA-A receptors. However, studies revealed that it possesses absolutely no GABA-mimetic activity.
Its true mechanism of action is related to effects on presynaptic terminals. The main molecular target is the $\alpha_2\delta$-subunit of voltage-gated calcium channels (N-type). By blocking these structures, the drug prevents $Ca^{2+}$ ions from entering the cell during membrane depolarization. This, in turn, leads to a reduction in the pathological release of excitatory neurotransmitters.
There are also additional hypotheses suggesting that the drug may inhibit the transport of excitatory amino acids and slightly stimulate the release of endogenous GABA.
Scope of application and adverse effects:
- Prescribed as a component of adjunctive therapy for partial seizure forms.
- Demonstrates extremely high clinical efficacy in the treatment of neuropathic pain syndromes.
- The spectrum of side effects includes dizziness, ataxia (coordination impairment), headaches, tremor, and somnolence.
Briefly: answers to topical questions
Which enzymes are involved in GABA catabolism?
The enzyme GABA transaminase is involved in the catabolism of gamma-aminobutyric acid. This specific enzyme is responsible for the breakdown of GABA in brain tissues. Inhibition of its activity leads to an increased concentration of the inhibitory neurotransmitter. The blockade of GABA transaminase underlies the mechanism of action of certain antiepileptic agents, such as valproic acid and vigabatrin (Vigabatrin).
How does valproic acid affect GABA metabolism?
Valproic acid increases GABA levels in the brain through a dual effect on its metabolism. The drug simultaneously impairs the inactivation of the neurotransmitter and stimulates its production:
- Inhibition of catabolism — blocks the enzyme GABA transaminase, which degrades GABA.
- Stimulation of synthesis — increases the activity of the enzyme glutamate decarboxylase, which is responsible for GABA synthesis.
As a result of these processes, the inhibitory neurotransmitter accumulates in the nervous tissue.
What are the pharmacokinetic features of gabapentin?
Compared to pregabalin, gabapentin is absorbed more slowly and has a lower bioavailability.
The three-letter rule (V-T-G): Vigabatrin — Turns off the enzyme (transaminase). Tiagabine — Terminates (inhibits) neurotransmitter reuptake. Gabapentin — Guards (blocks) calcium channels.
Class and exam questions
Does gabapentin interact directly with GABA receptors?
No. Despite being a chemical analogue of GABA and designed specifically for this purpose, it exhibits no direct GABA-mimetic activity.
Why is alcohol forbidden when taking tiagabine?
Tiagabine potentiates (enhances) the effects of any central nervous system depressants. Co-administration with ethanol, barbiturates, or benzodiazepines can lead to critical CNS depression.
Which of the listed agents is used for neuropathic pain?
Gabapentin shows high efficacy in neuropathic pain. The remaining agents from this list are used primarily to control seizures.
What else to study on this topic
- Structure and functions of GABA transaminase in nervous tissue
- Mechanisms of neuronal neurotransmitter reuptake
- Role of N-type calcium channels in synaptic transmission
- Pathogenesis of neuropathic pain and the role of excitatory amino acids
- Clinical differences between generalized and partial seizures
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Agents affecting GABA metabolism" and another 5,304 pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Agents Used in Psychiatry and Neurology"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.